Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

SARS-CoV-2 pseudovirus enters the host cells through spike protein-CD147 in an Arf6-dependent manner
Yun-Qi Zhou, Ke Wang, Xueyan Wang, et al.
Emerging Microbes & Infections (2022) Vol. 11, Iss. 1, pp. 1135-1144
Open Access | Times Cited: 33

Showing 1-25 of 33 citing articles:

SARS-CoV-2 Spike Protein Accumulation in the Skull-Meninges-Brain Axis: Potential Implications for Long-Term Neurological Complications in post-COVID-19
Zhouyi Rong, Hongcheng Mai, Saketh Kapoor, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 24
Mapping the global interactome of the ARF family reveals spatial organization in cellular signaling pathways
Laura Quirion, Amélie Robert, Jonathan Boulais, et al.
Journal of Cell Science (2024) Vol. 137, Iss. 9
Open Access | Times Cited: 7
Cyclophilin A/CD147 Interaction: A Promising Target for Anticancer Therapy
Jang Mi Han, Hye Jin Jung
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 16, pp. 9341-9341
Open Access | Times Cited: 33
SARS-CoV-2 and male infertility: from short- to long-term impacts
Pei Dai, Fei Qiao, Yi-shuan Elaine Chen, et al.
Journal of Endocrinological Investigation (2023) Vol. 46, Iss. 8, pp. 1491-1507
Open Access | Times Cited: 19
Persistence of spike protein at the skull-meninges-brain axis may contribute to the neurological sequelae of COVID-19
Zhouyi Rong, Hongcheng Mai, Gregor Ebert, et al.
Cell Host & Microbe (2024) Vol. 32, Iss. 12, pp. 2112-2130.e10
Open Access | Times Cited: 5
SARS-CoV-2 Receptors and Their Involvement in Cell Infection
П. П. Авдонин, E. Yu. Rybakova, S. K. Trufanov, et al.
Biochemistry (Moscow) Supplement Series A Membrane and Cell Biology (2023) Vol. 17, Iss. 1, pp. 1-11
Open Access | Times Cited: 13
Endomembrane remodeling in SARS-CoV-2 infection
Di Chen, Yan Zhao, Hong Zhang
Cell Insight (2022) Vol. 1, Iss. 3, pp. 100031-100031
Open Access | Times Cited: 19
The striking mimics between COVID-19 and malaria: A review
Emadeldin Hassan E. Konozy, Makarim Elfadil M. Osman, George Ghartey‐Kwansah, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 19
Molecular Analysis of SARS-CoV-2 Spike Protein-Induced Endothelial Cell Permeability and vWF Secretion
Yuexi Guo, Venkateswarlu Kanamarlapudi
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 6, pp. 5664-5664
Open Access | Times Cited: 11
SARS-CoV-2-associated lymphopenia: possible mechanisms and the role of CD147
Shaimaa Shouman, Nada Elkholy, Alaa E. Hussien, et al.
Cell Communication and Signaling (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 3
ARF6 is a host factor for SARS-CoV-2 infection in vitro
Carmen Mirabelli, Juliana Bragazzi Cunha, Jesse W. Wotring, et al.
Journal of General Virology (2023) Vol. 104, Iss. 6
Open Access | Times Cited: 9
A genome-wide association study for survival from a multi-centre European study identified variants associated with COVID-19 risk of death
Francesca Minnai, Filippo Biscarini, Martina Esposito, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 2
Thai traditional medicines reduce CD147 levels in lung cells: Potential therapeutic candidates for cancers, inflammations, and COVID-19
Kannika Sukadeetad, Bungorn Sripanidkulchai, Saowanaporn Tangsukworakhun, et al.
Journal of Ethnopharmacology (2024) Vol. 327, pp. 118042-118042
Closed Access | Times Cited: 2
Impact of BSG/CD147 gene expression on diagnostic, prognostic and therapeutic strategies towards malignant cancers and possible susceptibility to SARS-CoV-2
Jiewen Fu, Binghui Song, Jiaman Du, et al.
Molecular Biology Reports (2022) Vol. 50, Iss. 3, pp. 2269-2281
Open Access | Times Cited: 12
Lipid compartments and lipid metabolism as therapeutic targets against coronavirus
Daniella Cesar-Silva, Filipe S. Pereira‐Dutra, Ana L.M. Giannini, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 5
SLC38A9 regulates SARS-CoV-2 viral entry
Gaurav Datta, Neda Rezagholizadeh, Wendie A. Hasler, et al.
iScience (2024) Vol. 27, Iss. 7, pp. 110387-110387
Open Access | Times Cited: 1
COVID‐19 vaccine adverse events: Evaluating the pathophysiology with an emphasis on sulfur metabolism and endotheliopathy
Heidi N. du Preez, Johnson Lin, Glenn E. M. Maguire, et al.
European Journal of Clinical Investigation (2024) Vol. 54, Iss. 10
Open Access | Times Cited: 1
Enterovirus 71 enters human brain microvascular endothelial cells through an ARF6‐mediated endocytic pathway
Yongzhe Zhu, Xiaohang Wang, Zhiwei He, et al.
Journal of Medical Virology (2023) Vol. 95, Iss. 7
Closed Access | Times Cited: 4
Human Identical Sequences, hyaluronan, and hymecromone ─ the new mechanism and management of COVID-19
Shuai Yang, Ying Tong, Lu Chen, et al.
Molecular Biomedicine (2022) Vol. 3, Iss. 1
Open Access | Times Cited: 7
Impact of various buffers and weak bases on lysosomal and intracellular pH: Implications for infectivity of SARS‐CoV‐2
Jeffrey A. Kraut, Izaak J. Cheetham‐Wilkinson, Laura E. Swan, et al.
FASEB BioAdvances (2023) Vol. 5, Iss. 4, pp. 149-155
Open Access | Times Cited: 3
Repurposing Niclosamide as a Novel Anti-SARS-CoV-2 Drug by Restricting Entry Protein CD147
Zhe Yang, Qi Zhang, Xiaoqing Wu, et al.
Biomedicines (2023) Vol. 11, Iss. 7, pp. 2019-2019
Open Access | Times Cited: 3
Mapping the global interactome of the ARF family reveals spatial organization in cellular signaling pathways
Laura Quirion, Amélie Robert, Jonathan Boulais, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 2
Repurposing niclosamide as a novel anti-SARS-Cov-2 drug by restricting entry protein CD147
Zhe Yang, Qi Zhang, Xiaoqing Wu, et al.
Research Square (Research Square) (2023)
Open Access | Times Cited: 2
Inhibitory effects of SARS-CoV-2 spike protein and BNT162b2 vaccine on erythropoietin-induced globin gene expression in erythroid precursor cells from patients with β-thalassemia
Lucia Carmela Cosenza, Giovanni Marzaro, Matteo Zurlo, et al.
Experimental Hematology (2023) Vol. 129, pp. 104128-104128
Open Access | Times Cited: 2
The development and application of pseudoviruses: assessment of SARS-CoV-2 pseudoviruses
Conglian Tan, Nian Wang, Shanshan Deng, et al.
PeerJ (2023) Vol. 11, pp. e16234-e16234
Open Access | Times Cited: 2
Page 1 - Next Page

Scroll to top